Cargando…

Impact of the left common ostium following pulmonary vein isolation in AF: Systematic review and meta‐analysis

PURPOSE: Pulmonary vein isolation (PVI) through catheter ablation is the basis for the treatment of atrial fibrillation (AF). The left common ostium (LCO) is a high prevalence anatomical variation and has conflicting results in the effects on the prognosis following ablation. We undertook a systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronsoni, Rafael de March, Silvestrini, Tiago Luiz, Saffi, Marco Aurélio Lumertz, Leiria, Tiago Luiz Luz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237303/
https://www.ncbi.nlm.nih.gov/pubmed/35785389
http://dx.doi.org/10.1002/joa3.12710
Descripción
Sumario:PURPOSE: Pulmonary vein isolation (PVI) through catheter ablation is the basis for the treatment of atrial fibrillation (AF). The left common ostium (LCO) is a high prevalence anatomical variation and has conflicting results in the effects on the prognosis following ablation. We undertook a systematic review and meta‐analysis of studies that compared the arrhythmia recurrence rate after radiofrequency ablation or cryoablation balloon between patients with normal pattern pulmonary vein and patients with LCO. METHODS AND RESULTS: Results were pooled using a fixed or random effect, at the discretion of heterogeneity (>25%), in addition, we associated subgroup analysis in these cases and when clinically indicated. Fourteen non‐randomized studies totaling 3278 patients were included. In analyses using the two energies all patients: OR 1.01 (95% CI 0.84–1.23; P = .90, I (2) = 67%) and excluding patients with any type of persistent AF (PeAF) and those submitted to linear atrial lesion (LAL) OR 0.80 (95% CI 0.52–1.22; P = .30, I (2) = 71%). Using CRYO: all patients OR 1.34 (95% CI 1.03–1.74; P = .03, I (2) = 0%). Using RF: all patients—OR 0.55 (95% CI 0.32–0.95; P = .03, I (2) = 49%); excluding studies with long duration PeAF and the performance of LAL concomitant—OR 0.45 (95% CI 0.23–0.91; P = .03, I (2) = 44%). CONCLUSION: The results suggest a better prognosis in patients with LCO, submitted to PVI without additional LAL under RF energy in paroxysmal AF and short‐duration PeAF. In patients undergoing CRYO, the presence of LCO suggests a worse prognosis.